monoclonal antibodies

July 21, 2017

STING Agonists Help Overcome Lymphoma Patients’ Resistance to Rituxan, Study Finds

News

Therapies called STING agonists help overcome the resistance that lymphoma patients develop to monoclonal antibodies such as Rituxan (rituximab), a study reports. The research, “STING Activation Reverses Lymphoma-Mediated Resistance to Antibody ... Read more

September 28, 2015September 28, 2015

Research Suggests Progress in Clinical Endpoints For Follicular Lymphoma

News

A recent report written by John Sweetenham, MD, in HemOnc Today, revealed that progress is being made concerning the endpoints of clinical priority studies of follicular lymphoma (FL), which has improved overall survival rate of patients ... Read more